Guidelines

Hikma and Vectura plan to develop generic versions of GSK's Ellipta portfolio, utilizing Vectura's proprietary "open-inhale-close" dry powder inhaler device.

Amphastar Pharmaceuticals is bringing its Primatene Mist back to OTC aisles following Food and Drug Administration approval for a new, CFC-free formulation of the OTC treatment for mild asthma.

Michael Fraser, CEO of the Association of State and Territorial Health Officials will be honored by NACDS Foundation for addressing the opioid-abuse epidemic and other healthcare issues.

Drug Store News has partnered with CE Impact to offer our readers free access to two on-demand CE courses focused on vaccinations — click through to claim the code.

Bristol-Myers’ Empliciti provides a new immunotherapy combination for patients with relapsed or refractory multiple myeloma.

The FDA has given its blessing to Coherus BioSciences for Udenyca, which is a biosimilar of Amgen’s Neulasta.

Lupin has received the Food and Drug Administration's approval for generic Hectoral injection, which had a market value of about $133 million.

Janssen's Invokana has received the Food and Drug Administration's blessing, making it the first oral diabetes treatment approved for cardiovascular events.